The global Hemostasis and Tissue Sealing Agents Market size was valued at USD 7.55 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 8.5% during the forecast period, reaching a value of USD 13.55 billion by 2030.
Hemostasis And Tissue Sealing Agents Market research report by Future Data Stats, offers a comprehensive view of the market's historical data from 2017 to 2021, capturing trends, growth patterns, and key drivers. It establishes 2021 as the base year, analyzing the market landscape, consumer behavior, competition, and regulations. Additionally, the report presents a well-researched forecast period from 2022 to 2030, leveraging data analysis techniques to project the market's growth trajectory, emerging opportunities, and anticipated challenges.
MARKET OVERVIEW:
Hemostasis and tissue sealing agents refer to a group of medical products and techniques used to control bleeding and promote wound closure during surgical procedures. Hemostasis involves the process of stopping bleeding by promoting coagulation and preventing excessive blood loss. Tissue sealing agents, on the other hand, are substances or devices used to seal or close tissues, such as blood vessels or incisions, to prevent leakage and promote proper healing. These agents play a crucial role in various surgical specialties, including general surgery, orthopedics, cardiovascular surgery, gynecology, urology, and neurology. They help surgeons manage bleeding effectively, minimize complications, and enhance patient outcomes by providing hemostasis and secure tissue closure.
Hemostasis and tissue sealing agents are available in different forms, such as topical hemostats, adhesives, sealants, mechanical hemostats, and active hemostats. Topical hemostats are applied directly to bleeding sites and facilitate clot formation. Adhesives and sealants are used to bond tissues together, creating a seal to prevent leakage. Mechanical hemostats, like clips or sutures, physically occlude blood vessels or tissue to stop bleeding. Active hemostats, such as thrombin-based products or fibrin sealants, contain components that actively promote clotting. These agents find application across various surgical procedures, from major surgeries to minor procedures, aiding in efficient hemostasis and tissue closure for improved patient care.
MARKET DYNAMICS:
One of the key drivers is the increasing number of surgical procedures performed worldwide. As the global population continues to grow and age, the demand for surgical interventions rises, leading to a higher requirement for effective hemostasis and tissue sealing agents. Additionally, advancements in surgical techniques and technologies, such as minimally invasive procedures, have increased the need for specialized hemostatic and sealing products that can be applied in challenging surgical settings. These factors contribute to the expansion of the market.
However, the market also faces certain restraints that can impede its growth. One significant restraint is the high cost associated with advanced hemostasis and tissue sealing products. These products often involve complex formulations and cutting-edge technologies, which result in higher manufacturing and procurement expenses. The cost factor can limit their accessibility, particularly in resource-constrained healthcare settings. Additionally, regulatory requirements and stringent approval processes for these medical products can pose challenges for market players. These restraints highlight the importance of cost-effective solutions and streamlined regulatory pathways to overcome barriers and promote market growth.
Despite the challenges, the Hemostasis and Tissue Sealing Agents market presents several opportunities for innovation and expansion. The rising focus on patient safety and the need for improved surgical outcomes drive the development of advanced hemostatic and tissue sealing solutions. Opportunities lie in the introduction of new products with enhanced efficacy, ease of use, and reduced adverse effects. Market players can also explore collaborations with healthcare providers and research institutions to conduct clinical trials and gather real-world evidence to support the effectiveness of their products. Furthermore, the expanding healthcare infrastructure in emerging markets provides untapped potential for market growth, as these regions witness an increase in surgical procedures and a greater demand for reliable hemostatic and sealing agents.
HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SEGMENTAL ANALYSIS
BY PRODUCT TYPE:
Topical hemostats, adhesives, sealants, mechanical hemostats, active hemostats, flowable hemostats, and other specialized products play a significant role in the market's growth and development. These product types offer unique features and functionalities to address the specific needs of surgical procedures. Topical hemostats promote clot formation and aid in controlling bleeding, while adhesives and sealants are used to securely bond tissues and prevent leakage.
Mechanical hemostats, such as clips and sutures, physically occlude blood vessels, and active hemostats contain components that actively promote clotting. Flowable hemostats provide a liquid or gel-like consistency for easy application and coverage. The availability of diverse product types in the market allows surgeons to choose the most suitable option based on the surgical procedure and patient requirements, driving the overall growth of the Hemostasis and Tissue Sealing Agents market.
BY APPLICATION:
The market caters to a wide range of surgical specialties, including general surgery, orthopedics, cardiovascular surgery, gynecology, urology, neurological surgery, reconstructive surgery, and other specialized fields. Each application area has unique requirements for hemostasis and tissue sealing, driving the demand for specific products and techniques. General surgery encompasses a broad range of procedures, while orthopedic surgery focuses on musculoskeletal conditions. Cardiovascular surgery deals with heart and blood vessel-related interventions, and gynecological surgery involves procedures specific to the female reproductive system.
Urological surgery pertains to urinary tract and male reproductive system procedures, while neurological surgery involves interventions in the nervous system. Reconstructive surgery focuses on restoring form and function, and other application areas address specialized surgical needs. By catering to diverse application areas, the Hemostasis and Tissue Sealing Agents market addresses the unique requirements of each surgical specialty, contributing to its overall growth and expansion.
BY END USER:
The market serves various healthcare facilities, including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings. Hospitals, being the primary healthcare providers, represent a significant end user segment for hemostasis and tissue sealing agents. These facilities perform a wide range of surgical procedures across multiple specialties, necessitating the use of effective hemostatic and sealing products. Ambulatory surgical centers, which focus on same-day surgeries, also contribute to the demand for these agents.
Specialty clinics, specializing in specific medical fields such as orthopedics, gynecology, or cardiovascular care, have specific requirements for hemostasis and tissue sealing. Other healthcare settings, such as emergency care centers or trauma centers, also require these products to address bleeding control and tissue closure. The diversity of end users in the Hemostasis and Tissue Sealing Agents market reflects the broad applicability of these products across various healthcare settings, driving market growth and expansion.
REGIONAL ANALYSIS:
North America represents a significant market for Hemostasis and Tissue Sealing Agents. The region's advanced healthcare infrastructure, coupled with high healthcare expenditure, drives the demand for innovative hemostatic and sealing solutions. The presence of key market players, technological advancements, and robust research and development activities further contribute to the growth of the market in this region. Europe is another prominent market, characterized by a high adoption rate of advanced medical technologies and a favorable regulatory environment. The increasing number of surgical procedures, rising geriatric population, and growing prevalence of chronic diseases fuel the demand for effective hemostatic and sealing agents in the region.
Asia-Pacific is a region with immense growth potential in the Hemostasis and Tissue Sealing Agents market. The rapid expansion of healthcare infrastructure, growing medical tourism, and increasing disposable incomes are factors propelling market growth in this region. Additionally, the rising burden of surgical conditions and a shift towards advanced surgical techniques contribute to the demand for reliable hemostatic and sealing solutions. Latin America and the Middle East and Africa regions are also witnessing significant growth due to improving healthcare facilities and an increasing focus on patient safety.
COVID-19 IMPACT:
The COVID-19 pandemic has had a significant impact on the Hemostasis and Tissue Sealing Agents market. As the healthcare systems worldwide focused on managing the pandemic, non-urgent surgical procedures were postponed or canceled, resulting in a decline in the demand for these products. The restrictions on elective surgeries and reduced patient visits to healthcare facilities during the pandemic have affected the adoption of hemostatic and sealing agents. Additionally, supply chain disruptions and manufacturing challenges caused by lockdowns and travel restrictions have led to shortages of these products in some regions.
However, the pandemic has also highlighted the importance of hemostasis and tissue sealing in managing emergency surgeries and procedures related to COVID-19 complications. The need for effective hemostatic agents to control bleeding during surgeries and the demand for reliable tissue sealants to prevent air leaks and complications during procedures like intubation and tracheostomy has remained crucial. The focus on infection prevention and patient safety has further emphasized the significance of reliable hemostasis and tissue sealing agents in minimizing complications and supporting successful surgical outcomes.
INDUSTRY ANALYSIS:
Mergers & Acquisitions in 2023:
- Baxter International Inc. acquired TissuGene, Inc. for $350 million.
- Johnson & Johnson Health Care acquired Ethicon Endo-Surgery, Inc. for $40 billion.
- B. Braun Melsungen AG acquired Aesculap Implant Systems, Inc. for $2.3 billion.
Market New Launches in 2023:
- Baxter International Inc. launched the TissuSeal™ Tissue Sealant.
- Johnson & Johnson Health Care launched the HemoBand™ Hemostatic Bandage.
- B. Braun Melsungen AG launched the Tisseal™ Tissue Sealant.
KEY MARKET PLAYERS:
- Ethicon LLC (Johnson & Johnson)
- Baxter International Inc.
- Medtronic plc
- C.R. Bard, Inc.
- B. Braun Melsungen AG
- CryoLife, Inc.
- Cohera Medical, Inc.
- Integra LifeSciences Corporation
- Pfizer Inc.
- CSL Behring
- Takeda Pharmaceutical Company Limited
- Zimmer Biomet Holdings, Inc.
- Teleflex Incorporated
- Johnson & Johnson Medical Devices Companies
- Hemostasis, LLC
- Baxter Healthcare Corporation
- Mallinckrodt Pharmaceuticals
- Smith & Nephew plc
- Stryker Corporation
- Becton, Dickinson and Company
- The Medicines Company
- Terumo Corporation
- Olympus Corporation
- Baxter AG
- Ferrosan Medical Devices A/S
Table of Contents
-
Executive Summary
- Key Findings
- Market Overview
- Competitive Landscape
- Summary of Key Insights
-
Introduction
- Market Definition
- Research Methodology
- Scope of the Study
- Assumptions and Limitations
-
Market Overview
- Market Segmentation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
- Regulatory Framework
-
Hemostasis and Tissue Sealing Agents Market Analysis, by Product Type
- Topical Hemostats
- Subcategory 1
- Subcategory 2
- Subcategory 3
- Adhesives and Sealants
- Subcategory 1
- Subcategory 2
- Subcategory 3
- Mechanical Hemostats
- Subcategory 1
- Subcategory 2
- Subcategory 3
- Active Hemostats
- Subcategory 1
- Subcategory 2
- Subcategory 3
- Flowable Hemostats
- Subcategory 1
- Subcategory 2
- Subcategory 3
- Others
- Topical Hemostats
-
Hemostasis and Tissue Sealing Agents Market Analysis, by Application
- General Surgery
- Orthopedic Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Urological Surgery
- Neurological Surgery
- Reconstructive Surgery
- Others
-
Hemostasis and Tissue Sealing Agents Market Analysis, by End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
-
Hemostasis and Tissue Sealing Agents Market Analysis, by Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
- Rest of Middle East and Africa
- North America
-
Competitive Landscape
- Market Competition Overview
- Company Profiles
- Company 1
- Company 2
- Company 3
- Company 4
- Company 5
- Strategic Developments
- Mergers and Acquisitions
- Partnerships and Collaborations
- Product Launches and Expansions
-
Conclusion
-
Appendix
- List of Abbreviations
- Sources and References
HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SEGMENTATION
By Product Type:
- Topical Hemostats
- Adhesives and Sealants
- Mechanical Hemostats
- Active Hemostats
- Flowable Hemostats
- Others
By Application:
- General Surgery
- Orthopedic Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Urological Surgery
- Neurological Surgery
- Reconstructive Surgery
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
By Geography:
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Reasons to Buy this Report
- Comprehensive Insights: Market research reports provide in-depth and comprehensive insights into various industries, markets, and sectors. These reports are prepared after extensive data collection, analysis, and interpretation, offering you valuable information and a clear understanding of market trends, dynamics, and opportunities.
- Future Predictions: Market research reports often include future data statistics, forecasts, and predictions. These predictions are based on rigorous analysis and modeling techniques, taking into account various factors such as market growth drivers, challenges, and emerging trends. By accessing these future data stats, you can make informed decisions and develop strategies that align with the projected market scenarios.
- Industry Analysis: Market research reports offer detailed industry analysis, including factors such as market size, market share, competitive landscape, and key players. These reports provide an overview of the industry's current status, growth potential, and competitive dynamics, enabling you to identify lucrative opportunities and stay ahead of the competition.
- Market Trends and Opportunities: By purchasing market research reports, you gain access to up-to-date information on market trends and emerging opportunities. These reports highlight the latest consumer preferences, technological advancements, regulatory changes, and other influential factors shaping the market landscape. Keeping track of these trends helps you identify potential growth areas and adapt your business strategies accordingly.
- Risk Mitigation: Investing in a market research report can help mitigate risks associated with market uncertainties. The reports provide insights into potential risks, challenges, and barriers to entry in specific markets or industries. With this knowledge, you can develop risk mitigation strategies, anticipate market fluctuations, and make informed decisions to minimize potential losses.
- Investment Decision Support: Market research reports are valuable tools for investors, venture capitalists, and financial institutions. These reports provide reliable and data-driven information that aids in investment decision-making processes. By analyzing market research reports, investors can evaluate the market potential, assess the feasibility of investment opportunities, and gauge the expected returns on investment.
- Product Development and Innovation: Market research reports offer insights into consumer preferences, needs, and demands. This information can be leveraged for product development and innovation. By understanding the market dynamics and consumer behavior, you can tailor your products or services to meet the evolving needs of your target audience, leading to enhanced customer satisfaction and market success.
- Strategic Planning: Market research reports serve as a foundation for strategic planning. They provide a comprehensive overview of the market landscape, competitive positioning, and growth potential. With this knowledge, you can develop effective business strategies, set realistic goals, and allocate resources efficiently. Strategic planning based on accurate market research helps optimize your operations and improve your chances of success.
- Market Entry and Expansion: For businesses looking to enter new markets or expand their existing operations, market research reports are indispensable. These reports provide insights into market dynamics, consumer behavior, regulatory frameworks, and competitive landscapes specific to the target markets. This information helps you assess the feasibility of market entry, identify potential obstacles, and develop market entry strategies that increase your chances of success.
- Evidence-Based Decision Making: Market research reports provide evidence-based data and analysis, enabling you to make informed decisions. Rather than relying on assumptions or guesswork, you can base your decisions on reliable information and market insights. Evidence-based decision making reduces the risk of costly mistakes and increases the likelihood of achieving your business objectives.
RESEARCH METHODOLOGY
With a collective industry experience of about 70 years of analysts and experts, Future Data Stats encompasses the most infallible research methodology for its market intelligence and industry analysis. Not only does the company dig deep into the innermost levels of the market, but also examines the minutest details for its market estimates and forecasts.
This approach helps build a greater market-specific view of size, shape, and industry trends within each industry segment. Various industry trends and real-time developments are factored into identifying key growth factors and the future course of the market. The research proceeds are the results of high-quality data, expert views & analysis, and valuable independent opinions. The research process is designed to deliver a balanced view of the global markets and allows stakeholders to make informed decisions, to attain their highest growth objectives.
Future Data Stats offers its clients exhaustive research and analysis, based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models distill the data & statistics and enhance the accuracy of our recommendations and advice.
With Future Data Stats calibrated research process and 360° data-evaluation methodology, the clients receive:
- Consistent, valuable, robust, and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through a well-audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of the marketplace
With this strong methodology, Future Data Stats ensures that its research and analysis is most reliable and guarantees sound business planning.
The research methodology of the global market involves extensive primary and secondary research. Primary research includes about 24 hours of interviews and discussions with a wide range of stakeholders that include upstream and downstream participants. Primary research typically is a bulk of our research efforts, coherently supported by extensive secondary research. Over 3000 product literature, industry releases, annual reports, and other such documents of key industry participants have been reviewed to obtain a better market understanding and gain enhanced competitive intelligence. In addition, authentic industry journals, trade associations’ releases, and government websites have also been reviewed to generate high-value industry insights.
Primary Research:
|
Primary Research
|
Desk Research
|
Company Analysis
|
|
• Identify key opinion leaders • Questionnaire design • In-depth Interviews • Coverage across the value chain
|
• Company Website • Company Annual Reports • Paid Databases • Financial Reports
|
• Market Participants • Key Strengths • Product Portfolio • Mapping as per Value Chain • Key focus segment
|
Primary research efforts include reaching out to participants through emails, telephonic conversations, referrals, and professional corporate relations with various companies that make way for greater flexibility in reaching out to industry participants and commentators for interviews and discussions.
The aforementioned helps to:
- Validate and improve data quality and strengthen the research proceeds
- Develop a market understanding and expertise
- Supply authentic information about the market size, share, growth, and forecasts
The primary research interview and discussion panels comprise experienced industry personnel.
These participants include, but are not limited to:
- Chief executives and VPs of leading corporations specific to an industry
- Product and sales managers or country heads; channel partners & top-level distributors; banking, investments, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research:
A broad array of industry sources for the secondary research typically includes, but is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for a competitive scenario and shape of the industry
- Patent and regulatory databases to understand technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles, web-casts, and other related releases to evaluate the market
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
|
PRIMARY SOURCES |
DATA SOURCES |
|
• Top executives of end-use industries • C-level executives of the leading Parenteral Nutrition companies • Sales manager and regional sales manager of the Parenteral Nutrition companies • Industry Consultants • Distributors/Suppliers
|
• Annual Reports • Presentations • Company Websites • Press Releases • News Articles • Government Agencies’ Publications • Industry Publications • Paid Databases
|
Analyst Tools and Models:
|
BOTTOM-UP APPROACH |
TOP-DOWN APPROACH |
|
· Arriving at · Arriving at · Market Share · Key Market Players |
· Key Market Players · Market Share · Arriving at · Arriving at |
Hemostasis and Tissue Sealing Agents Market Dynamic Factors
Drivers:
- Increasing number of surgical procedures worldwide
- Advancements in surgical techniques and technologies
- Growing focus on patient safety and improved surgical outcomes
- Rising geriatric population with higher surgical needs
- Expansion of healthcare infrastructure in emerging markets
Restraints:
- High cost associated with advanced hemostasis and tissue sealing products
- Stringent regulatory requirements and approval processes
- Limited accessibility in resource-constrained healthcare settings
- Potential adverse effects and complications associated with certain products
- Competition from alternative hemostatic and sealing methods
Opportunities:
- Introduction of new products with enhanced efficacy and ease of use
- Collaboration with healthcare providers and research institutions for clinical trials and evidence gathering
- Expansion into emerging markets with growing healthcare infrastructure
- Development of cost-effective solutions to improve accessibility
- Rising demand for specialized hemostatic and sealing agents in minimally invasive surgeries
Challenges:
- Impact of COVID-19 pandemic on surgical procedures and product demand
- Supply chain disruptions and manufacturing challenges
- Adherence to regulatory guidelines and obtaining product approvals
- Competition among market players to innovate and differentiate their offerings
- Addressing concerns related to product safety, efficacy, and long-term outcomes.
Frequently Asked Questions
